CRYOPORT, INC. Induced Conversion of Convertible Debt Expense
CRYOPORT, INC. (CYRX) reported Induced Conversion of Convertible Debt Expense of $0 for the 12-month period ending 2015-03-31, per its 10-K filed 2015-05-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InducedConversionOfConvertibleDebtExpense · last filed 2015-05-19
- CRYOPORT, INC. induced conversion of convertible debt expense for the quarter ending 2015-03-31 was $0.00.
- CRYOPORT, INC. induced conversion of convertible debt expense for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. induced conversion of convertible debt expense for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- CRYOPORT, INC. induced conversion of convertible debt expense for the quarter ending 2014-06-30 was $0.00.
- CRYOPORT, INC. induced conversion of convertible debt expense for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- CRYOPORT, INC. induced conversion of convertible debt expense for fiscal 2014 was $13.71M.
| Period end | Induced Conversion of Convertible Debt Expense 2 month | Induced Conversion of Convertible Debt Expense 3 month | Induced Conversion of Convertible Debt Expense 6 month | Induced Conversion of Convertible Debt Expense 9 month | Induced Conversion of Convertible Debt Expense 12 month |
|---|---|---|---|---|---|
| 2015-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $0.00 derived: sum of 2 quarters · filed 2015-05-19 | $0.00 derived: sum of 3 quarters · filed 2015-05-19 | $0.00 10-K · filed 2015-05-19 | |
| 2014-12-31 | $0.00 10-Q · filed 2015-02-05 | $0.00 derived: sum of 2 quarters · filed 2015-02-05 | $0.00 10-Q · filed 2015-02-05 | $0.00 derived: sum of 4 quarters · filed 2015-05-19 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 3 quarters · filed 2015-05-19 | $552.75K derived: sum of 4 quarters · filed 2015-05-19 | |
| 2014-06-30 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2015-05-19 | $0.00 derived: sum of 2 quarters · filed 2015-05-19 | $552.75K derived: sum of 3 quarters · filed 2015-05-19 | $13.71M derived: sum of 4 quarters · filed 2015-05-19 | |
| 2014-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-19 | $552.75K derived: sum of 2 quarters · filed 2015-05-19 | $13.71M derived: sum of 3 quarters · filed 2015-05-19 | $13.71M 10-K · filed 2015-05-19 | |
| 2013-12-31 | $552.75K 10-Q · filed 2015-02-05 | $13.71M derived: sum of 2 quarters · filed 2015-02-05 | $13.71M 10-Q · filed 2015-02-05 | ||
| 2013-10-31 | $13.71M 10-Q · filed 2014-02-13 | ||||
| 2013-09-30 | $13.16M 10-Q · filed 2014-11-12 | $13.16M 10-Q · filed 2014-11-12 | |||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-13 | $0.00 derived: sum of 2 quarters · filed 2014-02-13 | $0.00 10-Q · filed 2014-02-13 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-18 | $0.00 10-Q · filed 2013-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |